Annual Accounts Payable
$15.42 M
+$8.82 M+133.72%
December 31, 2024
Summary
- As of March 10, 2025, IDYA annual accounts payable is $15.42 million, with the most recent change of +$8.82 million (+133.72%) on December 31, 2024.
- During the last 3 years, IDYA annual accounts payable has risen by +$13.32 million (+634.33%).
- IDYA annual accounts payable is now at all-time high.
Performance
IDYA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$15.42 M
+$2.85 M+22.71%
December 31, 2024
Summary
- As of March 10, 2025, IDYA quarterly accounts payable is $15.42 million, with the most recent change of +$2.85 million (+22.71%) on December 31, 2024.
- Over the past year, IDYA quarterly accounts payable has increased by +$9.13 million (+145.17%).
- IDYA quarterly accounts payable is now -2.93% below its all-time high of $15.89 million, reached on June 30, 2024.
Performance
IDYA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
IDYA Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +133.7% | +145.2% |
3 y3 years | +634.3% | +145.2% |
5 y5 years | +2075.0% | +145.2% |
IDYA Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +634.3% | -2.9% | +634.3% |
5 y | 5-year | at high | +2075.0% | -2.9% | +2154.5% |
alltime | all time | at high | +2229.5% | -2.9% | +2154.5% |
IDEAYA Biosciences Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $15.42 M(+133.7%) | $15.42 M(+22.7%) |
Sep 2024 | - | $12.57 M(-20.9%) |
Jun 2024 | - | $15.89 M(+152.6%) |
Mar 2024 | - | $6.29 M(-4.7%) |
Dec 2023 | $6.60 M(+54.2%) | $6.60 M(+27.6%) |
Sep 2023 | - | $5.17 M(-11.9%) |
Jun 2023 | - | $5.87 M(+34.1%) |
Mar 2023 | - | $4.38 M(+2.2%) |
Dec 2022 | $4.28 M(+103.8%) | $4.28 M(+17.4%) |
Sep 2022 | - | $3.65 M(-13.8%) |
Jun 2022 | - | $4.23 M(+25.7%) |
Mar 2022 | - | $3.36 M(+60.2%) |
Dec 2021 | $2.10 M | $2.10 M(-2.4%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $2.15 M(+2.1%) |
Jun 2021 | - | $2.11 M(+64.6%) |
Mar 2021 | - | $1.28 M(+34.4%) |
Dec 2020 | $953.00 K(+34.4%) | $953.00 K(-32.2%) |
Sep 2020 | - | $1.41 M(+47.6%) |
Jun 2020 | - | $952.00 K(+39.2%) |
Mar 2020 | - | $684.00 K(-3.5%) |
Dec 2019 | $709.00 K(-50.0%) | $709.00 K(-7.1%) |
Sep 2019 | - | $763.00 K(-29.4%) |
Jun 2019 | - | $1.08 M(-34.6%) |
Mar 2019 | - | $1.65 M(+16.5%) |
Dec 2018 | $1.42 M(+114.0%) | $1.42 M |
Dec 2017 | $662.00 K | - |
FAQ
- What is IDEAYA Biosciences annual accounts payable?
- What is the all time high annual accounts payable for IDEAYA Biosciences?
- What is IDEAYA Biosciences annual accounts payable year-on-year change?
- What is IDEAYA Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for IDEAYA Biosciences?
- What is IDEAYA Biosciences quarterly accounts payable year-on-year change?
What is IDEAYA Biosciences annual accounts payable?
The current annual accounts payable of IDYA is $15.42 M
What is the all time high annual accounts payable for IDEAYA Biosciences?
IDEAYA Biosciences all-time high annual accounts payable is $15.42 M
What is IDEAYA Biosciences annual accounts payable year-on-year change?
Over the past year, IDYA annual accounts payable has changed by +$8.82 M (+133.72%)
What is IDEAYA Biosciences quarterly accounts payable?
The current quarterly accounts payable of IDYA is $15.42 M
What is the all time high quarterly accounts payable for IDEAYA Biosciences?
IDEAYA Biosciences all-time high quarterly accounts payable is $15.89 M
What is IDEAYA Biosciences quarterly accounts payable year-on-year change?
Over the past year, IDYA quarterly accounts payable has changed by +$9.13 M (+145.17%)